Wisconsin AIDS/HIV Program

The Wisconsin AIDS/HIV Program is the lead agency in Wisconsin government responsible for coordinating the state’s public health response to the AIDS/HIV epidemic.


Logo used by the National Gay Men's HIV/AIDS Awareness Day

National Gay Men’s HIV/AIDS Awareness Day
September 27, 2016

National Gay Men's HIV/AIDS Awareness Day is a call to action to further raise awareness about the effects of HIV on gay and bisexual men. Since the first cases of AIDS were reported among gay and bisexual men more than 30 years ago, no group in the United States has been more affected by HIV. While gay and bisexual men -- including those who inject drugs -- make up only 2% of the overall population, they account for over half of the 1.2 million people living with HIV in the United States and two-thirds of all new HIV infections each year.

Male-to-male sexual contact has always accounted for the majority of cases of HIV in Wisconsin. Men who have sex with men (MSM), including MSM who inject drugs, accounted for an estimated 80% of HIV diagnoses in 2015. Mirroring national trends, the population experiencing the largest increase in new diagnoses in the past decade in Wisconsin is young Black MSM.

An estimated 5,000 MSM (including MSM/IDU) are living with HIV in Wisconsin, including those unaware of their infection. An estimated 36% of Black MSM is HIV-positive, compared to 10% of Hispanic and 4% of White MSM. Black females have an estimated HIV prevalence of 0.7% (7 in1,000) and females of other racial groups and non-MSM males of all racial groups have an HIV prevalence of less than 0.5%

For information and actions that support National Gay Men’s HIV/AIDS Awareness Day, visit the website of the Centers for Disease Control and Prevention (CDC) at http://www.cdc.gov/Features/NGMHAAD/. Additional information about the impact of HIV among gay and bisexual men is available on the CDC website at http://www.cdc.gov/hiv/group/msm/.


 

 



Clinical Guidelines on Pre-Exposure Prophylaxis (PrEP)

On May 14, 2014, the US Public Health Service released the first comprehensive clinical practice guidelines for PrEP (PDF, 868 KB). The guidelines recommend a daily HIV preventive medication for persons at substantial risk of HIV infection, as identified in the guidelines. When taken daily as directed, PrEP can reduce the risk of HIV infection by more than 90 percent.

The Centers for Disease Control and Prevention has published the clinical guidelines and a variety of resource materials for clinicians and consumers, including web-based facts sheets and videos, at http://www.cdc.gov/hiv/prevention/research/prep/index.html.

Guide for Wisconsin PrEP Providers

This newly developed clinical guide P-01197 (PDF, 297 KB) summarizes the recommended practices for HIV prevention through Pre-exposure Prophylaxis (PrEP) using the drug combination of tenofovir and emtricitabine (Truvada®). The guide has been compiled and reviewed by the Wisconsin Department of Health Services - AIDS/HIV Program, in collaboration with experienced local HIV clinicians and other health care providers.


Looking for HIV/AIDS information or related services in Wisconsin?

The Wisconsin HIV/STD/Hepatitis C Information and Referral Center (IRC) provides information and referral for HIV/AIDS, sexually transmitted diseases, and hepatitis services in Wisconsin. 

Contact the IRC toll-free at 800-334-2437 or visit the IRC website at http://www.arcw.org/aidsline.


Information regarding the Wisconsin AIDS/HIV Program

Centers for Disease Control and Prevention Web Advisory
This site may contain HIV prevention messages that some viewers may consider controversial.

Last Revised: September 20, 2016